Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/24228
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 17419/19718 (88%)
造访人次 : 6167200      在线人数 : 794
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    標題: 6-Alkylamino-2-(3-hydroxyphenyl)quinoIin-4-one Derivatives Induced Mitotic Arrest in Human Hep3B Cells
    作者: Mei-Hua Hsu (徐美華)
    Li-Chen Chou (周立琛)
    Ming-Hua Chen (陳明華)
    Chi-Hung Huang (黃濟鴻)
    Hui-Yi Lin (林慧怡)
    Shi-Hon Zhuang (莊仕弘)
    Chien-Ting Chen (陳建廷)
    Li-Jiau Huang (黃麗嬌)
    Sheng-Chu Kuo ()
    日期: 2011
    上傳時間: 2011-06-23 14:57:19 (UTC+8)
    摘要: In order to develop potential backup compounds for our previous identified new anticancer drug candidate,CHM-l-P-Na, a series of 6-alkylamino-2-(3-hydroxyphenyl)quinolin-4-one derivatives were designed and synthesized. The newly synthesized derivatives were evaluated for cytotoxicity and structure-activity relationships were established. Among those tested compounds, 6-pyrrolidino-2-(3-hydroxyphenyl)quinolin-4-one (A) was the most promising agent which was submitted to NCI for evaluation against 60 human cancer cell lines. Furthermore, the monophosphate of compound A (A-P) was synthesized and evaluated for antitumor activity in Hep3B Xenograft nude mice model. The results indicated that compound A-P has excellent antitumor activity when administrated either iv or po. With excellent antitumor activity profiles, compound A-P is considered potential backup compound for CHM-l-P-Na, which is currently under preclinical study.
    關聯: 2011年台俄有機、藥物與生物化學交流暨藥物化學研討會,起迄日:2011/04/06~2011/04/05,地點:溪頭台大實驗林
    显示于类别:[藥理學院] 2011年台俄有機、藥物與生物化學交流暨藥物化學研討會


    档案 描述 大小格式浏览次数
    pp-12.pdf70KbAdobe PDF416检视/开启

    在CNU IR中所有的数据项都受到原著作权保护.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈